Instead of asking:
“Did the scale go down today?”
Try asking:
“Did I practice the habits I want to become normal?”
Was there a satisfying starch at the center of your meals? Did you eat the foods you planned to eat most of the time? Did you move your body? Did you get back to your normal routine after an imperfect meal instead of turning it into an imperfect week?
Those are signals you can actually use.
Category: Motivational
The way he handled things was caught on video
What If the Scale Is Giving You the Wrong Feedback?
What If the Scale Is Giving You the Wrong Feedback with Dr. Douglas J. Lisle
What if the scale isn’t actually telling you whether your plan is working?
In a recent Starch Solution Community call, Dr. Doug Lisle joined us live and explained why day-to-day weight can be so misleading and why it often sends people in the wrong direction. He also shared a much better way to measure progress, including what to track instead, how long to give the process and why slow progress may be far more meaningful than it looks.
Read the full article to see the simple shift that can make weight loss feel a lot less confusing.
Rail Bike Picnic Adventure
Picnic Menu
* 🍇 Grapes
* 🍌 Banana
* 🥑 Avocado
* 🫒 Olives
* 🥕 Baby carrots
* 🌱 Turnips – peeled & chunked
* 🥔 Cooled baby potatoes
* 🍠 Cooled sweet potato chunks
* 🫘 Oil-free hummus
* 🍲 Red lentil stew — in thermos
* Sprouted grains English muffins
Germs, Genes or Lifestyle?
The Holy Trinity – diet, fitness, sleep
PETER A. MCCULLOUGH, MD, MPH
Sept 17, 2026
The Holy Trinity – diet, fitness,
sleep – and why the best
anxiety remedy is a hard
workout. Dr McCullough with
Emmy Award Winner Kerstin
Lindquist
The Pandemic Retrospective
Dr. McCullough frames the era as an “awakening”,
* He asserts the virus was lab-engineered in Wuhan and that the spike protein persists in the body, causing long COVID clots, heart damage, and autoimmunity.
* He claims the mRNA vaccines deliver ~10x the spike protein load of natural infection, citing a Barham et al. paper, and calls for their removal from market.
* He praises Novavax as the safest option and notes only ~9% of Americans still take boosters.
* His preferred approach: early treatment – nasal sprays, gargling, the “McCullough Protocol,” monoclonal antibodies, and oral ivermectin as the “superstar” drug
* He discusses Anthony Fauci’s diary, alleging Fauci developed a post-vaccine blood clot but concealed it, and that Fauci sought clemency from Biden.
Daily Health Non-Negotiables
McCullough outlines his own routine:
* Nasal spray + gargle twice daily (saltwater, iodine, or xylitol-based products like Immune Defense, Xlear/Spry) to disrupt viral replication.
* “Ultimate Spike Detox” — nattokinase, bromelain, and curcumin to dissolve spike protein, plus sweating (sauna) as an elimination pathway.
* His Diet (the “Holy Trinity”): diet, fitness, sleep. He prioritizes fish, beans, nuts, egg whites, nonfat dairy; lean chicken and beef, avoids pork (citing genetic vaccines in pork), and cuts the “three S’s” — sugars/sweets, starches, and saturated fat.
* Alcohol: urges a 90-day alcohol-free challenge, noting even one drink can disrupt sleep architecture for months.
* Sleep: older adults need less sleep (7–8 hours), and physical activity is his top anxiety/stress/sleep remedy.
* He plugs Vesper (a nootropic non-alcoholic cocktail) and improved non-alcoholic beers for social events.
Where to Find Him
Dr. Peter A. McCullough, MD, MPH, appointments www.peteramcculloughmd.com
Chief Scientific Officer, The Wellness Company www.twc.health/focalpoints
President, McCullough Foundation, www.mcculloughfnd.org
Author, Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex and NYT Best Seller Vaccines: Mythology, Ideology, and Reality
One of the greatest discoveries in human biology… God is Amazing!
Lp(a) After
Lp(a)HORIZON:
From Causal
Biomarker to
Unproven
Therapeutic
Target
Sep 16, 2026
The first major Lp(a)-lowering outcomes trial fails its primary endpoint, and the entire class — olpasiran, lepodisiran, zerlasiran, muvalaplin — must now answer a harder question than it expected.
In a result that will reshape clinical lipidology for a decade, Novartis announced on September 4 that its flagship antisense oligonucleotide (ASO), pelacarsen, failed to meet its primary endpoint in the pivotal Lp(a)HORIZON trial. Across more than 8,300 patients with elevated Lp(a) and established cardiovascular disease, pelacarsen did lower lipoprotein(a) — potently, and as designed — but that reduction did not translate into fewer heart attacks, strokes, cardiovascular deaths, or urgent revascularizations.